Enzyme Replacement Therapy Market Report
RA00751
Enzyme Replacement Therapy Market, by End Use (Hospitals, Infusion Centers, Others), Enzymes (Imiglucerase, Agalsidase Beta, Taliglucerase, Velaglucerase Alfa, Laronidase, Alglucosidase Alfa, Galsulfase, Idursulfase, Pancreatic Enzymes, Pegademase, Others), Therapeutic Area (Gaucher Disease, Fabry Disease, Pompe Disease, SCID, MPS, Others), Route Of Administration (Oral, Parenteral): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global enzyme replacement therapy market is estimated to surpass $13,473.2 million by 2027, exhibiting a CAGR of 8.0% from 2020 to 2027.
The report offers meticulous analysis of the global enzyme replacement therapy market by thoroughly studying different assets of the market including major segments, market dynamics, regional market conditions, investment opportunities, and top players functioning in the market.
The report also sheds light on present scenario and upcoming trends and developments that are contributing in the growth of the market. In addition, key market boomers and opportunities driving the market growth are provided in the report. Besides, restraints and challenges that hold power to obstruct the market growth are also profiled in the report. The report also offers Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.
Based on the key forces molding the market, the report offers future perspective and growth outlook of the global market. The report offers market size and forecast by keenly evaluating every segment of the global enzyme replacement therapy market. Regional market breakdown of these segments is also offered in the report. The report divides the global enzyme replacement therapy market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-divided to profile detailed panorama of the enzyme replacement therapy market across major countries in specific regions. Moreover, the report reveals some of the recent developments, trends, and forthcoming opportunities in every region.
Apart from these insights, the highlights of major players functioning in the global enzyme replacement therapy market is also covered in the report. A detailed overview of 10 leading players operating in the global enzyme replacement therapy market is provided to understand their status and hold over the market share. Company profile of each player includes several data points such as short overview of the company, major company executives, company’s financial status and revenue, major business strategies implemented by company, innovative developments or initiatives taken by company to shove their position and standout among other competitors in the global enzyme replacement therapy market.
RESEARCH METHODOLOGY
The report is formulated by in-house market analysts by deeply scrutinizing the market scenario. The market predictions stated in the report have been derived using proven research methodologies and analytical tools & models. Use of such advanced and effective tools, helps market analysts in scrutinizing, filtering, and offering highly accurate data and predictions. The report delivers an extensive research and analysis backed with a variety of factual data, which mainly include interviews with industry players, trustworthy and renowned sources of statistics, and regional intelligence. The insights provided in the report can help investors in understanding investment suitability and market players to grab opportunities for investments, partnerships, and developments in the global market.
The research report is formed by collating different statistics and information concerning the enzyme replacement therapy market. For instance, around 18 hours of interviews and deliberations have been performed with a group of stakeholders and investors, including upstream and downstream members. Primary research is the main part of the research efforts; however, it is reasonably supported by all-encompassing secondary research. About 5,900 product type literatures, market publications, company annual reports, and other such relevant documents of key market players have been studied, for better understanding of market penetration. Furthermore, trustworthy industry newsletters, medical journals, trade associations’ publications, and government websites have also been evaluated for extracting vital industry insights.
KEY MARKET BENEFITS
- The report offers market size and forecast for the period from 2019 to 2027
- This report highlights trends, innovations, and novel development along with a thorough quantitative analysis of the enzyme replacement therapy market during the period of forecast
- The prevailing and upcoming opportunities along with the tactical assessment of the global enzyme replacement therapy market growth is provided
- The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key innovations in the enzyme replacement therapy market
- Information on leading market players, Porter’s Five Analysis, and top winning business strategies is offered
- The development plans and initiatives undertaken by the top market players are highlighted to understand the competitive landscape of the market
KEY MARKET SEGMENTS
The report segments the global market into end use ,enzymes ,therapeutic area ,route of administration
- End Use: Hospitals, Infusion Centers, Others
- Enzymes: Imiglucerase, Agalsidase Beta, Taliglucerase, Velaglucerase Alfa, Laronidase, Alglucosidase Alfa, Galsulfase, Idursulfase, Pancreatic Enzymes, Pegademase, Others
- Therapeutic Area: Gaucher Disease, Fabry Disease, Pompe Disease, SCID, MPS, Others
- Route Of Administration: Oral, Parenteral
Regionally, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA.
- The North American countries explored in the report are the U.S., Canada, and Mexico.
- The European countries explored in the report are Germany, the U.K., France, Spain, Italy, and Rest of Europe.
- The Asian countries explored in the report are Japan, China, India, Australia, and Rest of Asia-Pacific.
- The countries in LAMEA explored in the report are Brazil, Saudi Arabia, South Africa, South Korea, and Rest of LAMEA.
KEY PLAYERS
The key players profiled in the report are Amicus Therapeutics, Inc., Alexion Pharmaceuticals Inc., Actelion (Janssen), Recordati Rare Diseases and many more.
The report outlines the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the leading players of the enzyme replacement therapy market.
- Shire Plc;
- Sanofi S.A.
- Biomarin Pharmaceutical Inc.
- AbbVie
- Alexion Pharmaceuticals Inc.
- Allergan plc
- Horizon Pharma Public Limited Company
- Actelion (Janssen)
- Recordati Rare Diseases
- Protalix Biotherapeutics
- Amicus Therapeutics, Inc.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Enzyme Replacement Therapy Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Enzyme Replacement Therapy Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Enzyme Replacement Therapy Market, By Application
5.1. Overview
5.2 Hospitals
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Infusion Centers
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Others
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Enzyme Replacement Therapy Market, By Incontinence Type
6.1. Overview
6.2 Imiglucerase
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Agalsidase Beta
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Taliglucerase
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Velaglucerase Alfa
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Laronidase
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Alglucosidase Alfa
6.7.1 Definition, key trends, growth factors, and opportunities
6.7.2 Market size analysis, by region, 2020-2027
6.7.3 Market share analysis, by country, 2020-2027
6.8 Galsulfase
6.8.1 Definition, key trends, growth factors, and opportunities
6.8.2 Market size analysis, by region, 2020-2027
6.8.3 Market share analysis, by country, 2020-2027
6.9 Idursulfase
6.9.1 Definition, key trends, growth factors, and opportunities
6.9.2 Market size analysis, by region, 2020-2027
6.9.3 Market share analysis, by country, 2020-2027
6.10 Pancreatic Enzymes
6.10.1 Definition, key trends, growth factors, and opportunities
6.10.2 Market size analysis, by region, 2020-2027
6.10.3 Market share analysis, by country, 2020-2027
6.11 Pegademase
6.11.1 Definition, key trends, growth factors, and opportunities
6.11.2 Market size analysis, by region, 2020-2027
6.11.3 Market share analysis, by country, 2020-2027
6.12 Others
6.12.1 Definition, key trends, growth factors, and opportunities
6.12.2 Market size analysis, by region, 2020-2027
6.12.3 Market share analysis, by country, 2020-2027
6.13 Research Dive Exclusive Insights
6.13.1 Market attractiveness
6.13.2 Competition heatmap
-
7. Enzyme Replacement Therapy Market, By Indication
7.1. Overview
7.2 Gaucher Disease
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Fabry Disease
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Pompe Disease
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 SCID
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 MPS
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Others
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Research Dive Exclusive Insights
7.8.1 Market attractiveness
7.8.2 Competition heatmap
-
8. Enzyme Replacement Therapy Market, By Treatment
8.1. Overview
8.2 Oral
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Parenteral
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
9. Enzyme Replacement Therapy Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Application, 2020-2027
9.1.1.2 Market size analysis, By Incontinence Type , 2020-2027
9.1.1.3 Market size analysis, By Indication, 2020-2027
9.1.1.4 Market size analysis, By Treatment, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Application, 2020-2027
9.1.2.2 Market size analysis, By Incontinence Type , 2020-2027
9.1.2.3 Market size analysis, By Indication, 2020-2027
9.1.2.4 Market size analysis, By Treatment, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Application, 2020-2027
9.1.3.2 Market size analysis, By Incontinence Type , 2020-2027
9.1.3.3 Market size analysis, By Indication, 2020-2027
9.1.3.4 Market size analysis, By Treatment, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Application, 2020-2027
9.2.1.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.1.3 Market size analysis, By Indication, 2020-2027
9.2.1.4 Market size analysis, By Treatment, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Application, 2020-2027
9.2.2.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.2.3 Market size analysis, By Indication, 2020-2027
9.2.2.4 Market size analysis, By Treatment, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Application, 2020-2027
9.2.3.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.3.3 Market size analysis, By Indication, 2020-2027
9.2.3.4 Market size analysis, By Treatment, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Application, 2020-2027
9.2.4.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.4.3 Market size analysis, By Indication, 2020-2027
9.2.4.4 Market size analysis, By Treatment, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Application, 2020-2027
9.2.5.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.5.3 Market size analysis, By Indication, 2020-2027
9.2.5.4 Market size analysis, By Treatment, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Application, 2020-2027
9.2.6.2 Market size analysis, By Incontinence Type , 2020-2027
9.2.6.3 Market size analysis, By Indication, 2020-2027
9.2.6.4 Market size analysis, By Treatment, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Application, 2020-2027
9.3.1.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.1.3 Market size analysis, By Indication, 2020-2027
9.3.1.4 Market size analysis, By Treatment, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Application, 2020-2027
9.3.2.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.2.3 Market size analysis, By Indication, 2020-2027
9.3.2.4 Market size analysis, By Treatment, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Application, 2020-2027
9.3.3.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.3.3 Market size analysis, By Indication, 2020-2027
9.3.3.4 Market size analysis, By Treatment, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Application, 2020-2027
9.3.4.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.4.3 Market size analysis, By Indication, 2020-2027
9.3.4.4 Market size analysis, By Treatment, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Application, 2020-2027
9.3.5.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.5.3 Market size analysis, By Indication, 2020-2027
9.3.5.4 Market size analysis, By Treatment, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Application, 2020-2027
9.3.6.2 Market size analysis, By Incontinence Type , 2020-2027
9.3.6.3 Market size analysis, By Indication, 2020-2027
9.3.6.4 Market size analysis, By Treatment, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Application, 2020-2027
9.4.1.2 Market size analysis, By Incontinence Type , 2020-2027
9.4.1.3 Market size analysis, By Indication, 2020-2027
9.4.1.4 Market size analysis, By Treatment, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Application, 2020-2027
9.4.2.2 Market size analysis, By Incontinence Type , 2020-2027
9.4.2.3 Market size analysis, By Indication, 2020-2027
9.4.2.4 Market size analysis, By Treatment, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Application, 2020-2027
9.4.3.2 Market size analysis, By Incontinence Type , 2020-2027
9.4.3.3 Market size analysis, By Indication, 2020-2027
9.4.3.4 Market size analysis, By Treatment, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Application, 2020-2027
9.4.4.2 Market size analysis, By Incontinence Type , 2020-2027
9.4.4.3 Market size analysis, By Indication, 2020-2027
9.4.4.4 Market size analysis, By Treatment, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Application, 2020-2027
9.4.5.2 Market size analysis, By Incontinence Type , 2020-2027
9.4.5.3 Market size analysis, By Indication, 2020-2027
9.4.5.4 Market size analysis, By Treatment, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Shire Plc; Sanofi S.A.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Biomarin Pharmaceutical Inc.
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 AbbVie
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Alexion Pharmaceuticals Inc.
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 Allergan plc
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Horizon Pharma Public Limited Company
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Actelion (Janssen)
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Recordati Rare Diseases
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Protalix Biotherapeutics
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 Amicus Therapeutics, Inc.
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
